Strategic Healthcare Marketing Planning

Introduction and Context

Healthcare marketing planning is the disciplined process through which a healthcare organisation analyses its environment, selects priority markets, creates patient and stakeholder value, allocates resources, and evaluates performance. It differs from conventional consumer marketing because healthcare decisions involve clinical risk, information asymmetry, regulation, professional ethics, third-party payers, and multiple decision-makers. The person receiving care may not be the person choosing the provider or paying the bill. Consequently, strategic healthcare marketing cannot be reduced to advertising or patient acquisition. It encompasses service design, access, trust, reputation, relationships, patient experience, clinical quality communication, and organisational sustainability.

A marketing plan translates organisational purpose into coordinated market action. It connects the mission of a hospital, clinic, insurer, diagnostic centre, pharmaceutical service, or digital-health organisation with identifiable patient and stakeholder needs. A strong plan answers five questions:

1. Where are we now?
2. Where should we compete and for whom?
3. What value will we create and communicate?
4. What resources and capabilities are required?
5. How will performance, quality, ethics, and learning be monitored?

Healthcare managers should distinguish between a strategic marketing plan, which establishes direction over a medium-term horizon, and an operational marketing plan, which specifies campaigns, activities, schedules, budgets, and responsibilities. Strategy precedes tactics; otherwise, organisations may spend heavily on promotion without improving access, service capacity, or patient experience.

Learning Objectives

By the end of this chapter, the reader should be able to:

• explain the role and distinctive characteristics of strategic healthcare marketing planning;
• conduct situation analysis using PESTLE, SWOT/TOWS, competitor analysis, and Porter’s Five Forces;
• formulate market-oriented, measurable, ethical, and feasible objectives;
• design an integrated healthcare services marketing mix using the 7Ps;
• allocate resources and establish implementation responsibilities;
• select meaningful performance indicators and interpret marketing outcomes;
• identify ethical, regulatory, technological, and governance risks in healthcare marketing.

1. The Strategic Logic of a Healthcare Marketing Plan

A healthcare organisation creates value when it improves health outcomes and service experiences while using resources responsibly. Marketing planning therefore requires alignment among four elements:

• Strategic intent: mission, vision, values, and desired position.
• Market insight: patient needs, population health trends, payer requirements, referral patterns, and competitor behaviour.
• Organisational capability: clinical expertise, facilities, technology, workforce, finances, partnerships, and data.
• Execution and control: programmes, budgets, measures, accountability, and corrective action.

The planning process is iterative rather than strictly linear. Market intelligence may reveal that a proposed service is not clinically feasible; implementation data may show that the original target segment was too broad; patient feedback may require redesign of the service process. Strategic planning is therefore a learning system.

A useful value proposition states the target audience, the need addressed, the distinctive benefit, and the reason to believe the organisation can deliver it. For example: “For adults with poorly controlled diabetes in the metropolitan region, the integrated diabetes programme provides coordinated medical, nutritional, and remote-monitoring support, delivered by a multidisciplinary team with measurable follow-up.” This is stronger than “We provide excellent healthcare,” because it identifies a segment, need, offer, and basis for credibility.

2. Situation Analysis: Understanding the Strategic Starting Point

Situation analysis is the systematic assessment of internal capabilities and external conditions. It should combine quantitative evidence—such as utilisation, waiting time, market share, retention, and financial data—with qualitative evidence, including interviews, complaints, observation, focus groups, and stakeholder narratives.

2.1 Internal analysis

Internal analysis examines resources, competences, processes, culture, and performance. Relevant questions include:

• Which services produce strong clinical outcomes and sustainable margins?
• Where do patients experience delay, confusion, or poor coordination?
• What clinical specialties, technologies, locations, and partnerships differentiate the organisation?
• Does the workforce have the skills and capacity required by the proposed strategy?
• Are data systems sufficiently reliable for targeting and evaluation?
• Is the organisation trusted by patients, referrers, payers, regulators, and the community?

A resource should not be called a strategic strength merely because it exists. It becomes strategically valuable when it contributes to patient value, is relatively scarce, is difficult to imitate, and is supported by organisational systems. A high-quality imaging device, for example, may not create advantage if every competitor possesses similar equipment and the organisation has long delays or insufficient radiologists.

2.2 External analysis

External analysis considers demographic, epidemiological, economic, social, technological, legal, political, and environmental influences. It should identify both current conditions and plausible future changes. Healthcare demand is shaped not only by population size but also by age structure, disease prevalence, health literacy, insurance coverage, income, transport, culture, and confidence in institutions.

2.3 Patient and stakeholder insight

The “customer” in healthcare is a network rather than a single individual. Important stakeholders may include patients, family caregivers, physicians, nurses, referring clinicians, employers, insurers, government agencies, suppliers, regulators, and community organisations. Their needs may conflict. A payer may prioritise cost control, while a patient prioritises convenience and a clinician prioritises clinical appropriateness.

Segmentation should therefore use meaningful variables, such as clinical need, risk, behaviour, geography, referral source, payer status, digital access, and service preferences. Segmentation must not produce discriminatory exclusion or deny necessary care. In public and mission-driven systems, segments may be used to improve access and tailor support rather than to select only low-risk or profitable patients.

3. PESTLE Analysis

PESTLE identifies broad environmental forces:

PESTLE is not a list of news headlines. Each factor should be assessed for its likely impact, time horizon, uncertainty, and strategic response. Managers may classify issues as high, medium, or low priority, but the classification should be supported by evidence. Scenario planning is useful where uncertainty is high—for example, when reimbursement reform or a new technology may substantially alter service economics.

4. SWOT and TOWS: From Description to Strategic Choice

SWOT summarises internal strengths and weaknesses and external opportunities and threats. Examples include:

• Strengths: trusted clinicians, convenient location, integrated records, strong referral relationships.
• Weaknesses: fragmented scheduling, limited evening capacity, inconsistent service communication.
• Opportunities: rising demand for chronic-care coordination, employer health programmes, virtual follow-up.
• Threats: new entrants, workforce shortages, reduced reimbursement, misinformation, cyberattacks.

SWOT becomes valuable only when it leads to choices. The TOWS matrix converts the four categories into strategic approaches:

A common error is to list “good reputation” as a strength without testing whether it is recognised by the relevant segment and supported by evidence. Similarly, “competition” is not automatically a threat; it may stimulate innovation or create partnership opportunities.

5. Competitor and Market Analysis

Competitor analysis assesses organisations that meet the same or substitute needs. Direct competitors may provide similar clinical services in the same geography. Indirect competitors may include retail clinics, virtual providers, self-care solutions, alternative providers, or patients’ decision to delay care.

A competitor profile should examine:

• target segments and positioning;
• service portfolio and clinical scope;
• access, location, hours, waiting time, and digital interfaces;
• prices, packages, payment arrangements, and payer contracts;
• clinical outcomes, accreditation, and patient experience;
• workforce, technology, partnerships, and referral networks;
• brand reputation and communication claims;
• likely response to a new strategic initiative.

Managers should avoid copying competitors without understanding their capabilities and economics. Benchmarking is most useful when it asks why performance differs and what can realistically be improved. Publicly available information, mystery shopping conducted ethically, patient research, referral interviews, accreditation reports, and market databases may be used. Confidential information should never be obtained improperly.

6. Porter’s Five Forces in Healthcare

Porter’s framework evaluates industry attractiveness and structural pressure through five forces:

1. Rivalry among existing providers: rivalry increases when many providers offer similar services, demand is slow-growing, fixed costs are high, and switching is easy.
2. Threat of new entrants: entry is affected by capital requirements, licensing, professional workforce, reputation, technology, and access to referral or payer networks.
3. Bargaining power of buyers: patients, employers, insurers, and public purchasers may exert power through price sensitivity, purchasing concentration, information, and switching options.
4. Bargaining power of suppliers: clinicians, device manufacturers, pharmaceutical firms, technology vendors, and scarce specialist labour can influence cost and availability.
5. Threat of substitutes: substitutes include home monitoring, telehealth, prevention, retail services, competing clinical pathways, or no treatment.

The framework must be adapted carefully. Healthcare markets are shaped by regulation, professional norms, public funding, and social missions that are not fully captured by competitive economics. A service may be strategically important even if it is not highly profitable, especially where it supports emergency readiness, equity, or the organisation’s public mandate.

7. Setting Marketing Objectives

Objectives translate strategic intent into measurable results. Effective objectives are specific, measurable, achievable, relevant, time-bound, and ethically acceptable. They should cover more than volume. A hospital that increases appointments while worsening waiting time or clinical outcomes has not achieved strategic success.

A balanced objective set may include:

• Market outcomes: awareness, appropriate demand, referral share, or reach in an underserved population.
• Patient outcomes: satisfaction, trust, access, adherence, continuity, or reported experience.
• Operational outcomes: waiting time, appointment completion, digital adoption, or process reliability.
• Financial outcomes: revenue, contribution, cost per acquisition, or payer mix.
• Equity and social outcomes: language access, geographic reach, reduction of avoidable disparities.
• Quality and safety outcomes: readmission, adverse events, appropriateness, and clinical outcome measures.

7.1 Useful marketing calculations

The percentage change in a measure is:

The old value must be non-zero, and both values must use the same definition and time period. If completed consultations rise from 8,000 to 9,200, the change is ((9,200 − 8,000) ÷ 8,000) × 100 = 15%.

Conversion rate is commonly calculated as:

The denominator must be defined consistently. For a digital appointment campaign, an organisation might use completed bookings divided by qualified landing-page visits, not total website traffic. If 240 qualified visitors produce 18 completed bookings, conversion is 7.5%.

Customer acquisition cost is:

Attributable expenditure may include media, campaign labour, and relevant technology costs. CAC should not be interpreted without considering patient lifetime value, clinical appropriateness, payer mix, and contribution margin. A low CAC can be undesirable if it attracts patients whose needs cannot be safely served.

7.2 Leading and lagging indicators

Leading indicators, such as qualified enquiries, referral engagement, staff training completion, and appointment availability, provide early signals. Lagging indicators, such as revenue, retention, reputation, and clinical outcomes, show results after a delay. A dashboard should include both. Metrics should have an owner, data source, reporting frequency, target, tolerance range, and agreed corrective action.

8. Resource Allocation and Marketing Governance

Resource allocation determines whether the plan is executable. Budgets should cover research, service redesign, communication, workforce capability, technology, training, evaluation, and contingency. Promotion should not receive the entire budget when the strategic problem is inadequate capacity or poor access.

A practical allocation process is:

1. estimate the resources required to achieve each objective;
2. identify fixed, variable, one-time, and recurring costs;
3. assess expected value, feasibility, risk, and equity;
4. rank initiatives using transparent criteria;
5. assign accountable owners and decision rights;
6. reserve resources for measurement, compliance, and adaptation;
7. review allocations as evidence changes.

Healthcare marketing governance should include clinical, legal, privacy, compliance, finance, information security, and patient-representation perspectives. Campaign approval should verify that claims are accurate, evidence-based, comprehensible, culturally appropriate, and not coercive. Marketing data should be collected for a defined purpose, minimised, secured, retained appropriately, and used consistently with consent and applicable privacy law.

9. The Healthcare Services Marketing Mix: The 7Ps

The 7Ps provide an integrated design framework. They should be treated as interdependent decisions rather than seven isolated promotional categories.

9.1 Product: the healthcare service and value experience

The product includes the core benefit, the actual service, and augmented elements. The core benefit may be diagnosis, relief, recovery, prevention, reassurance, or improved functioning. The actual service includes clinical procedures, professional interaction, scheduling, and care coordination. Augmented elements include reminders, education, transport assistance, digital access, follow-up, and navigation.

Healthcare products are frequently redesigned as pathways rather than isolated episodes. A chronic-care product may include assessment, personalised planning, group education, medication review, remote monitoring, and escalation protocols. Product design must preserve clinical appropriateness and avoid encouraging unnecessary utilisation.

9.2 Price: financial and non-financial sacrifice

Price includes fees, co-payments, premiums, deductibles, and payment terms. It also includes time, travel, waiting, uncertainty, emotional effort, and perceived risk. Transparent estimates, package design, financial counselling, and convenient payment can improve value without compromising care.

Price decisions must respect reimbursement rules, competition law, professional ethics, and equity. Differential pricing may be justified by payer arrangements or cost structures, but opaque pricing can damage trust. Managers should distinguish price from cost and from value: a low price does not guarantee affordability if travel and waiting costs are high.

9.3 Place: access and delivery channels

Place concerns where and how the service is delivered. It includes facility location, clinic hours, transport, home care, telehealth, mobile units, pharmacies, referral channels, and digital scheduling. Channel design should consider clinical suitability, digital exclusion, disability access, privacy, continuity, and emergency escalation.

A virtual consultation is not automatically a superior channel. It may improve convenience for follow-up but be inappropriate where physical examination, diagnostic testing, or safeguarding assessment is necessary.

9.4 Promotion: informing, educating, and building trust

Promotion includes advertising, public relations, professional communication, community outreach, content, social media, referral engagement, patient education, and reputation management. Healthcare promotion should support informed choice rather than exploit fear or vulnerability.

Claims should be clear about evidence, limitations, eligibility, risks, and alternatives. Testimonials require permission and must not imply guaranteed outcomes. Search optimisation and social media can improve discoverability, but organisations must monitor misinformation, protect confidentiality, and avoid responding publicly to identifiable patient cases.

9.5 People: the service workforce and stakeholders

Patients experience the organisation through people. Recruitment, credentialing, training, supervision, workload, communication skills, cultural competence, and psychological safety affect both patient experience and clinical quality. Internal marketing is essential: employees must understand the value proposition, have the capability to deliver it, and be able to report failures without fear.

People decisions should not encourage staff to prioritise sales targets over clinical appropriateness. Incentives require safeguards against overtreatment, cherry-picking, discriminatory access, and inaccurate documentation.

9.6 Process: the patient journey and operating system

Process encompasses referral, registration, triage, scheduling, consultation, diagnostics, treatment, discharge, follow-up, complaints, and escalation. Journey mapping can reveal duplication, handoff failures, hidden waiting, and avoidable patient effort.

Process performance may be monitored through cycle time, abandonment, first-contact resolution, missed appointments, referral leakage, complaints, and safety indicators. A redesigned process should be piloted and evaluated rather than assumed to work because it appears efficient.

9.7 Physical evidence: visible cues of quality and trust

Because services are intangible and variable, patients infer quality from physical evidence: cleanliness, signage, accessibility, privacy, staff identification, uniforms, equipment, printed information, website design, waiting-room conditions, and the coherence of the brand. Physical evidence cannot substitute for clinical quality, but inconsistent or poor environments can undermine confidence.

10. Integration: From Strategy to Implementation

An integrated plan should present a coherent chain:

Insight → segment and need → value proposition → objectives → 7Ps → resources → measures → learning.

For each initiative, the implementation plan should specify activities, owner, timing, dependencies, budget, risk controls, and success measures. A RACI-style arrangement may clarify who is responsible for delivery, accountable for the result, consulted during design, and informed of progress.

Implementation commonly fails for four reasons: inadequate operational capacity, unclear ownership, poor internal communication, and measurement of activity rather than value. For example, counting social-media impressions does not establish that appropriate patients received accessible, accurate information or that care improved.

11. Illustrative Case: Riverside Integrated Diabetes Programme

This is a fictional illustrative case.

Background

Riverside Health Network operates two hospitals and six primary-care centres. It has respected endocrinologists but experiences fragmented diabetes care, long waits for education appointments, and high rates of missed follow-up. A private virtual provider has entered the market.

Problem

The board initially proposes a promotional campaign to increase diabetes referrals. The marketing team argues that demand generation without redesign would worsen waiting times and damage trust.

Analysis

PESTLE identifies rising diabetes prevalence, payer interest in prevention, expanding remote-monitoring technology, privacy obligations, and concern about digital exclusion. SWOT identifies specialist expertise and an integrated record as strengths, but fragmented scheduling and limited educator capacity as weaknesses. Opportunities include group education and pharmacist partnerships; threats include virtual competitors and workforce shortages.

Competitor analysis shows that the virtual provider offers rapid appointments but limited local laboratory integration. Porter analysis indicates strong rivalry, moderate buyer power, high supplier power for specialist staff, and a growing substitute threat from remote care.

Patient interviews reveal that people value one coordinated plan, evening appointments, language support, and practical help with medicines and food. Referrers want rapid feedback and clear escalation pathways.

Approach

Riverside adopts the value proposition: “Coordinated diabetes support close to home, combining specialist review, practical education, pharmacist input, and safe remote follow-up.” The plan includes:

• Product: a risk-stratified pathway with specialist review, group education, medication support, and remote monitoring for eligible patients;
• Price: transparent payer communication and assistance for patients facing financial barriers;
• Place: evening group sessions, primary-care delivery, and telehealth for clinically appropriate follow-up;
• Promotion: evidence-based community education and referral materials, avoiding promises of cure;
• People: training for primary-care teams, educators, pharmacists, and navigators;
• Process: central referral triage, shared care plans, reminders, and escalation rules;
• Physical evidence: consistent signage, accessible multilingual materials, and a redesigned patient portal.

Objectives include reducing median time from referral to first education session by 30% in twelve months, increasing completed follow-up among enrolled patients, improving patient-reported coordination, and monitoring clinical outcomes without excluding high-need patients.

Outcome and evaluation

After a six-month pilot, completed education attendance improves, but portal use is lower among older patients and those with limited digital access. Riverside therefore introduces telephone support and community-based assistance rather than treating low portal use as patient failure. The pilot also identifies educator workload risk, leading to revised staffing and group-session capacity.

Learning points

The case demonstrates that marketing strategy is inseparable from service operations. The organisation did not merely advertise a service; it designed a credible, accessible, measurable, and ethically governed value proposition. It also used evaluation to adapt the plan rather than assuming that digital adoption or promotional reach represented success.

12. Ethics, Regulation, and Contemporary Developments

Healthcare marketing must respect autonomy, beneficence, non-maleficence, justice, privacy, confidentiality, and professional integrity. Particular risks include fear-based messaging, misleading comparative claims, hidden fees, exploitation of vulnerable groups, use of health data without appropriate authority, discriminatory targeting, and promotion of clinically unnecessary services.

Regulatory requirements vary by jurisdiction but commonly concern advertising substantiation, professional licensing, informed consent, privacy and security, accessibility, consumer protection, competition, medical-device claims, and records management. Managers should obtain legal and clinical review rather than treating compliance as a final administrative step.

AI and analytics can support segmentation, demand forecasting, appointment reminders, sentiment analysis, and personalised education. However, models may reproduce historical inequities, infer sensitive health conditions, or produce inaccurate content. Responsible use requires a defined purpose, data governance, human oversight, bias testing, explainability appropriate to the context, security, audit trails, and a mechanism for correction. AI-generated promotional content must not fabricate clinical evidence or imply that a system replaces professional judgement.

Contemporary healthcare marketing is increasingly shaped by patient-generated reviews, omnichannel access, value-based care, population health, health literacy, sustainability, and community accountability. Reputation is now built through the cumulative service experience, not only through controlled messages. Organisations should therefore integrate marketing, quality improvement, patient experience, clinical governance, and public relations.

Challenges and Limitations of Strategic Planning

Strategic plans can become obsolete when assumptions change. Market data may be incomplete, patient preferences may be difficult to interpret, and competitor intelligence may be unavailable. Attribution is also challenging: a patient may encounter several communication channels and referral influences before choosing a provider. Short-term campaign metrics may conflict with long-term trust and health outcomes.

Frameworks such as SWOT and Porter’s Five Forces simplify complex systems. They are aids to judgement, not substitutes for evidence. Excessive focus on competition can obscure partnerships, public-health responsibilities, and equity. Finally, a plan can be analytically excellent but fail through weak leadership, insufficient funding, staff resistance, or poor execution.

Best practice is therefore to document assumptions, involve patients and frontline professionals, use mixed evidence, test initiatives on a limited scale, protect vulnerable groups, monitor unintended consequences, and revise the plan through structured learning cycles.

Chapter Summary

Strategic healthcare marketing planning aligns organisational purpose, patient and stakeholder needs, capabilities, service design, resources, and performance management. Situation analysis combines internal evidence with PESTLE, stakeholder insight, competitor analysis, and Porter’s Five Forces. SWOT becomes strategically useful when converted into SO, WO, ST, and WT choices through TOWS.

Effective objectives address market, patient, operational, financial, equity, quality, and safety outcomes. Metrics such as percentage change, conversion rate, and customer acquisition cost are useful only when their denominators, attribution rules, and ethical implications are explicit. Resource allocation must fund service capability and evaluation, not merely promotion.

The 7Ps—product, price, place, promotion, people, process, and physical evidence—form an integrated healthcare services marketing mix. Their design must reflect clinical appropriateness, access, trust, patient experience, regulation, and operational feasibility. Ethical governance, privacy, equity, and responsible use of technology are central to credible healthcare marketing. A strategic plan is ultimately a cycle of insight, choice, implementation, measurement, and adaptation.

Key Terms

Strategic marketing plan: A medium-term framework linking market insight, objectives, value creation, resources, and evaluation.

Situation analysis: Systematic assessment of internal capabilities and external conditions.

PESTLE: Analysis of political, economic, social, technological, legal, and environmental forces.

SWOT: Summary of strengths, weaknesses, opportunities, and threats.

TOWS: A method for converting SWOT findings into strategic alternatives.

Competitor analysis: Assessment of current and potential providers and substitutes.

Porter’s Five Forces: Framework analysing rivalry, entrants, buyers, suppliers, and substitutes.

Segmentation: Division of a broad market into meaningful groups with related needs or characteristics.

Value proposition: Clear statement of target audience, need, benefit, and reason to believe.

Marketing objective: A defined result that guides action and evaluation.

Conversion rate: Percentage of eligible opportunities producing a specified desired action.

Customer acquisition cost: Attributable acquisition expenditure per new acquired patient.

Healthcare services marketing mix: The integrated 7Ps framework used to design and deliver services.

Patient journey: The sequence of interactions and experiences before, during, and after care.

Physical evidence: Tangible cues through which patients infer service quality and trust.

Internal marketing: Activities that equip and motivate employees to deliver the service promise.

Marketing governance: Structures that ensure accountability, compliance, ethics, and risk control.

Health equity: Fair opportunity for people to attain appropriate health and healthcare without avoidable disadvantage.

Omnichannel care: Coordinated delivery across physical, digital, telephone, and community channels.

Leading indicator: An early measure that signals likely future performance.

Review Questions

Short Answer Questions

1. Why is healthcare marketing broader than advertising?
2. What is the difference between SWOT and TOWS?
3. Name the five forces in Porter’s framework.
4. Define a value proposition in healthcare services.
5. Identify the seven elements of the healthcare services marketing mix.

Long Answer Questions

1. Explain how PESTLE analysis can influence the strategic marketing plan of a hospital.
2. Discuss the ethical and managerial issues involved in segmenting healthcare markets.
3. Explain why marketing objectives should include operational, quality, and equity measures in addition to financial measures.
4. Analyse the relationship among product, people, process, and physical evidence in healthcare service delivery.
5. Describe a governance system for approving and monitoring a healthcare marketing campaign.

Analytical / Application Questions

1. A diagnostic centre has strong clinical expertise but long waiting times and fragmented booking. Use SWOT/TOWS and the 7Ps to propose a twelve-month strategy.
2. A telehealth provider wants to enter a rural market. Apply PESTLE and Porter’s Five Forces, then identify the principal risks and required capabilities.
3. A campaign generates 400 qualified enquiries and 28 completed appointments at an attributable cost of 5,600 currency units. Calculate the conversion rate and customer acquisition cost, explain the assumptions behind each calculation, and recommend two additional measures needed to judge whether the campaign was successful.

Multiple Choice Questions with Answers

Question 1

Which activity best represents strategic healthcare marketing planning?

A. Increasing social-media posts without changing the service

B. Aligning market insight, service design, resources, and measurable objectives

C. Reducing all prices below competitors

D. Delegating marketing entirely to an advertising agency

Correct Answer: B. Aligning market insight, service design, resources, and measurable objectives

Question 2

In a TOWS analysis, an SO strategy primarily seeks to:

A. Use strengths to exploit opportunities

B. Use weaknesses to exploit opportunities

C. Use strengths to eliminate all threats

D. Match threats only with financial controls

Correct Answer: A. Use strengths to exploit opportunities

Question 3

Which of the following is an external factor in a PESTLE analysis?

A. Staff clinical competence

B. Appointment scheduling efficiency

C. Changes in privacy legislation

D. Internal organisational culture

Correct Answer: C. Changes in privacy legislation

Question 4

Which force concerns the influence of scarce specialist clinicians and technology vendors?

A. Threat of substitutes

B. Bargaining power of suppliers

C. Rivalry among existing providers

D. Bargaining power of buyers

Correct Answer: B. Bargaining power of suppliers

Question 5

A campaign receives 240 qualified visitors and produces 18 completed bookings. What is its conversion rate?

A. 5.0%

B. 7.5%

C. 13.3%

D. 18.0%

Correct Answer: B. 7.5%

Question 6

Which example belongs most directly to the ‘process’ element of the 7Ps?

A. A redesigned referral and triage workflow

B. A new hospital logo

C. A specialist’s professional credentials

D. A discounted consultation fee

Correct Answer: A. A redesigned referral and triage workflow

Question 7

Why should customer acquisition cost be interpreted alongside other measures?

A. Because a low acquisition cost always indicates poor quality

B. Because it does not reveal appropriateness, outcomes, retention, or contribution by itself

C. Because it cannot be calculated in healthcare

D. Because it is identical to the service price

Correct Answer: B. Because it does not reveal appropriateness, outcomes, retention, or contribution by itself

Question 8

Which is an example of physical evidence in healthcare services?

A. A patient’s diagnosis

B. A payer’s reimbursement rule

C. Accessible signage and a clean, private waiting area

D. A competitor’s market share

Correct Answer: C. Accessible signage and a clean, private waiting area

Question 9

Which objective is most strategically complete?

A. Increase advertising impressions as much as possible

B. Become famous in the local market

C. Reduce referral-to-education waiting time by 30% in twelve months while monitoring patient experience and equity

D. Offer the lowest price in every service line

Correct Answer: C. Reduce referral-to-education waiting time by 30% in twelve months while monitoring patient experience and equity

Question 10

A major governance risk in using AI for healthcare marketing is that AI may:

A. Make every campaign more expensive

B. Eliminate the need for clinical oversight

C. Create or amplify bias and use sensitive data inappropriately

D. Prevent organisations from measuring website visits

Correct Answer: C. Create or amplify bias and use sensitive data inappropriately